Follow
Ammar Tarar (Ph.D.)
Ammar Tarar (Ph.D.)
Verified email at vandals.uidaho.edu
Title
Cited by
Cited by
Year
Wearable skin sensors and their challenges: A review of transdermal, optical, and mechanical sensors
A Ahmad Tarar, U Mohammad, S K. Srivastava
Biosensors 10 (6), 56, 2020
672020
Efficient expression of soluble recombinant protein fused with core-streptavidin in bacterial strain with T7 expression system
A Tarar, EM Alyami, CA Peng
Methods and Protocols 3 (4), 82, 2020
82020
Anticancer activity, mechanism, and delivery of allyl isothiocyanate
A Tarar, S Peng, S Cheema, CA Peng
Bioengineering 9 (9), 470, 2022
72022
Eradication of Myrosinase-Tethered Cancer Cells by Allyl Isothiocyanate Derived from Enzymatic Hydrolysis of Sinigrin
Ammar Tarar, Esmael M. Alyami, Ching-An Peng
Pharmaceutics, 2022
72022
Enhancement of antibacterial activity of sinigrin-capped silver nanoparticles in combination with myrosinase
A Tarar, CA Peng
Journal of Environmental Chemical Engineering 10 (3), 107796, 2022
42022
Organelle and molecular targeting
LS Milane, MM Amiji
CRC Press, 2021
32021
Mesenchymal stem cells anchored with thymidine phosphorylase for doxifluridine-mediated cancer therapy
A Tarar, EM Alyami, CA Peng
RSC advances 11 (3), 1394-1403, 2021
32021
Less phagocytosis of viral vectors by tethering with CD47 ectodomain
EM Alyami, A Tarar, CA Peng
Journal of Materials Chemistry B 10 (1), 64-77, 2022
22022
Antineoplastic Potency of Sinigrin-functionalized Silver Nanoparticles on Tumor Cells Transfected with Myrosinase-encoded Plasmids
A Tarar, CA Peng
BioNanoScience 14 (1), 81-92, 2024
2024
Anti-HER2 scFv antibody-directed lentiviral delivery of myrosinase for eradicating HER2+ cancer cells after dosing prodrug sinigrin
AA Tarar, CA Peng
Cancer Research 82 (12_Supplement), 3291-3291, 2022
2022
Eradication of Myrosinase-Tethered Cancer Cells by Allyl Isothiocyanate Derived from Enzymatic Hydrolysis of Sinigrin. Pharmaceutics 2022, 14, 144
A Tarar, EM Alyami, CA Peng
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022
2022
Escaping Immune Clearance
EM Alyami, A Tarar, CA Peng
Organelle and Molecular Targeting, 113-128, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–12